Di Napoli Mario
Neurological Section, SMDN-Center for Cardiovascular Medicine and Cerebrovascular, Disease Prevention, 41 Via Trento, I-67039-Sulmona, AQ, Italy.
Curr Opin Investig Drugs. 2004 Mar;5(3):295-305.
Although elevated cholesterol levels have been associated with coronary heart disease, the evidence for a role of cholesterol in stroke is less well defined. Epidemiological studies indicate that high lipid levels are linked with an increase in ischemic stroke, while low lipid levels may increase the risk of hemorrhagic stroke. Lipid lowering with statins reduces the incidence of ischemic stroke without increasing the frequency of hemorrhagic stroke. The benefits of statins on stroke may be due to a combination of mechanisms. Statins lower cholesterol levels and reduce the progression of atherosclerotic plaque formation in carotid arteries, and the incidence of emboli from cardiac, aortic and carotid sites. Furthermore, statins may produce cholesterol-independent effects such as improving cerebral blood flow and reducing inflammation and oxidative stress, which could limit the size of an ischemic lesion. Statins offer potential benefits for reducing the incidence and improving the prognosis of stroke.
尽管胆固醇水平升高与冠心病有关,但胆固醇在中风中所起作用的证据尚不明确。流行病学研究表明,高血脂水平与缺血性中风的增加有关,而低血脂水平可能会增加出血性中风的风险。使用他汀类药物降低血脂可降低缺血性中风的发生率,而不会增加出血性中风的发生频率。他汀类药物对中风的益处可能是多种机制共同作用的结果。他汀类药物可降低胆固醇水平,减少颈动脉粥样硬化斑块形成的进展,以及心脏、主动脉和颈动脉部位栓子的发生率。此外,他汀类药物可能产生不依赖胆固醇的作用,如改善脑血流量、减轻炎症和氧化应激,这可能会限制缺血性病变的大小。他汀类药物在降低中风发生率和改善中风预后方面具有潜在益处。